Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PCCA antisense RNA 1 (PCCA-AS1)
- Target
- PCCA-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA
01
Overview
PCCA antisense RNA 1 (PCCA-AS1) is a long non-coding RNA (lncRNA) transcribed from the genome in the opposite (antisense) orientation to the PCCA gene locus. Like other antisense lncRNAs, it may have regulatory effects on its sense gene (PCCA) through mechanisms such as transcriptional interference, splicing modulation, or RNA stability modulation, although no specific functions or disease associations have been validated for PCCA-AS1. Antisense lncRNAs are an emerging class of regulatory RNAs that play diverse roles in gene expression, but only a limited number, such as those with proven functions or disease associations, are considered therapeutic targets at present[1][3].
- Other names
- LOC107984574PCCA-AS1
02
Mechanism of action
Not established for this RNA.
03
Biological functions
Regulation of gene expression (likely through antisense mechanisms acting on PCCA or related loci)
04
Disease associations
Other (possible, unconfirmed roles in metabolic disorders involving PCCA gene regulation)
05
Safety considerations
None described.
06
Interacting drugs
None known.
07
Biomarkers
None established.
Beyond the preview
Go deeper on PCCA antisense RNA 1 (PCCA-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PCCA antisense RNA 1 (PCCA-AS1).